Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor
2016 ◽
Vol 7
(5)
◽
pp. 737-743
◽
2011 ◽
Vol 33
(7)
◽
pp. 973-989
◽
Keyword(s):
2016 ◽
Vol Volume 8
◽
pp. 521-529
◽